Imagine living with HIV for over a decade and facing the daily challenges of frailty as you age. This is the reality for many older adults, who often find that their physical strength and ability to perform everyday tasks diminish over time. A new clinical trial is exploring whether a combination of two drugs, dasatinib and quercetin, can help improve physical function for these individuals. In this study, 80 participants aged 50 and older will receive either the drug combination or a placebo over 12 weeks. The goal is to see if this treatment can enhance their ability to walk and carry out daily activities. If successful, this could mean a significant improvement in quality of life for older adults with HIV, allowing them to regain some of the physical abilities they may have lost. However, it’s important to remember that this is still a trial, and results will take time to analyze. The hope is that these findings could lead to new treatments that help older adults with HIV live healthier, more active lives.
Can a New Drug Combination Help Older Adults with HIV Regain Strength?
Photo by Navy Medicine / Unsplash
What this means for you:
A new drug combo could help older adults with HIV regain strength and improve their quality of life. More on HIV-Associated Frailty
Case report on asciminib plus ponatinib or axitinib in CML relapse with B lymphoblastic blast crisis New combo drug stops leukemia that fought back against two drugs
medRxiv · Apr 24, 2026
Narrative review examines antioxidant metabolites for autism spectrum disorder in children Could antioxidant nutrients help children with autism spectrum disorder?
Frontiers · Apr 19, 2026
Review of flavonoids shows preclinical neuroprotective potential in Parkinson's disease models Parkinson's drugs may need a new partner
Frontiers · Apr 18, 2026
Review of quercetin in metabolic diseases shows promise but lacks clinical validation. Review suggests quercetin may have multiple beneficial effects on metabolic conditions
Frontiers · Apr 13, 2026